Aetna · Reimbursement Past Sema · US health-plan appeal rights

Reimbursement Past Sema denied for failing step therapy by Aetna?

Q: How long do I have to appeal a Aetna Reimbursement Past Sema denial?

Internal appeal window: Typically 180 days from the denial date. External review window: Typically 60–120 days after the final internal denial. The clock starts from the date on the denial letter.

Step-therapy denials usually flip when the appeal documents that prior alternatives were tried and failed, or were contraindicated, or aren't safe for the patient.

By Michael John Ryan, Founder & Privacy Officer, DenialHelp, LLC

Last reviewed 2026-05-10

Policy data current as of 2026-04-26

US health-plan appeal rights

Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules

Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.

Internal appeal window

Typically 180 days from the denial date

External review window

Typically 60–120 days after the final internal denial

What Aetna typically requires

Aetna's specific coverage criteria for reimbursement past sema are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

Source policy: Aetna Clinical Policy Bulletin — Weight Reduction Medications (retroactive reimbursement)

The Aetna angle on Reimbursement Past Sema

## Why Aetna Applies Step Therapy to Semaglutide

Aetna's medical and pharmacy policies frequently require patients to try and fail one or more alternative medications before semaglutide will be covered — a practice known as step therapy or "fail-first." This requirement is driven by Aetna's formulary tier placement and utilization-management protocols. The denial does not mean semaglutide is never covered; it means the plan wants documented evidence that the patient has moved through the required prior steps.

## Why This Denial Is Appealable

Step-therapy denials are appealable when: (a) the patient has already tried and failed — or is medically contraindicated from — the required prior medications; (b) the required step drugs are clinically inappropriate for this specific patient based on comorbidities, prior adverse events, or other documented reasons; or (c) the step-therapy protocol itself conflicts with applicable clinical guidelines. Many states also have step-therapy exception laws for fully-insured plans that mandate expedited override processes.

## Federal Appeal Framework

Internal appeal: ACA §2719 and ERISA §503 guarantee the right to a full-and-fair internal review. Aetna must disclose the exact step-therapy criteria applied and the clinical rationale for the denial.
External review: After a final internal denial, an independent external review organization can evaluate whether the step-therapy requirement was clinically appropriate as applied within approximately four months.
Expedited review: If delay would seriously jeopardize health, request expedited processing simultaneously.
State protections: If the plan is a state-regulated (fully-insured) plan in a state with step-therapy exception legislation, additional override rights may apply on top of the federal framework.

## Documentation to Gather

1. Step-therapy criteria from Aetna — download the current policy from Aetna's provider portal. Identify every drug and every duration requirement in the protocol. 2. Prior medication history with outcomes — dated records for each required step drug: start date, stop date, dose tried (as recorded in chart), reason for discontinuation (inadequate response, adverse event, contraindication). 3. Prescriber medical-necessity letter — should state why the patient's clinical situation requires semaglutide specifically, and should address each step-therapy requirement by name, explaining either that it was satisfied or why it cannot safely be applied. 4. Supporting clinical guidelines — reference the relevant guideline organization (e.g., applicable ADA or obesity-medicine society guidelines) generically to show alignment between the prescribing decision and current standard of care.

## Criteria-Mapping Structure

Build a step-by-step tracking table:

| Aetna Step Requirement (copy verbatim) | Patient History Response | |---|---| | Step 1 drug name + required duration | Dates tried, outcome, chart reference | | Step 2 drug name + required duration (if applicable) | Dates tried, outcome, chart reference | | Exception criteria (e.g., contraindication) | Clinical documentation supporting exception |

A complete, systematic response to each step is the single most important factor in step-therapy appeal success.

Next steps

Find the date on the denial letter — your appeal window starts there.
Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
Request the insurer's claim file in writing — they must provide it.
Submit your appeal in writing with new clinical evidence and a physician statement.

Get the letter drafted

DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.

Start my appeal — $30 with code SEO25 →

Related appeal guides

Other Aetna appeals

Other denial reasons for Aetna Reimbursement Past Sema

denied as not medically necessary denied as non-formulary denied for missing prior authorization denied as experimental or investigational denied as not FDA-approved for this use

This guide describes general US federal appeal rights based on Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules. Your specific plan documents (Summary of Benefits and Coverage, Evidence of Coverage) override anything here. DenialHelp is not your lawyer and not your physician — we draft appeal letters that your physician signs. Outcomes depend on your insurer's decision and factors outside our control. Reviewed by Michael John Ryan on 2026-05-10. Editorial standards: denialhelp.com/authors.